Differential Regulation of Cathepsin S and Cathepsin L in Interferon γ–treated Macrophages

Cathepsin S (catS) and cathepsin L (catL) mediate late stages of invariant chain (Ii) degradation in discrete antigen-presenting cell types. Macrophages (Mφs) are unique in that they express both proteases and here we sought to determine the relative contribution of each enzyme. We observe that catL plays no significant role in Ii cleavage in interferon (IFN)-γ–stimulated Mφs. In addition, our studies show that the level of catL activity is significantly decreased in Mφs cultured in the presence of IFN-γ whereas catS activity increases. The decrease in catL activity upon cytokine treatment occurs despite the persistence of high levels of mature catL protein, suggesting that a specific inhibitor of the enzyme is up-regulated in IFN-γ–stimulated peritoneal Mφs. Similar inhibition of activity is observed in dendritic cells engineered to overexpress catL. Such enzymatic inhibition in Mφs exhibits only partial dependence upon Ii and therefore, other mechanisms of catL inhibition are regulated by IFN-γ. Thus, during a T helper cell type 1 immune response catL inhibition in Mφs results in preferential usage of catS, such that major histocompatibility complex class II presentation by all bone marrow–derived antigen-presenting cell is regulated by catS.

[1]  Christoph Peters,et al.  Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant Chain , 2002, The Journal of experimental medicine.

[2]  L. Santambrogio,et al.  IFN Regulatory Factor-1 Regulates IFN-γ-Dependent Cathepsin S Expression1 , 2002, The Journal of Immunology.

[3]  A. Rudensky,et al.  A Role for Cathepsin L and Cathepsin S in Peptide Generation for MHC Class II Presentation1 , 2002, The Journal of Immunology.

[4]  H. Ploegh,et al.  The p41 isoform of invariant chain is a chaperone for cathepsin L , 2001, The EMBO journal.

[5]  A. Rudensky,et al.  Cathepsin S Regulates the Expression of Cathepsin L and the Turnover of γ-Interferon-inducible Lysosomal Thiol Reductase in B Lymphocytes* , 2001, The Journal of Biological Chemistry.

[6]  H. Ploegh,et al.  Cytokines Regulate Proteolysis in Major Histocompatibility Complex Class II–Dependent Antigen Presentation by Dendritic Cells , 2001, The Journal of experimental medicine.

[7]  R. Homer,et al.  Interferon γ Induction of Pulmonary Emphysema in the Adult Murine Lung , 2000, The Journal of experimental medicine.

[8]  J. Falgueyret,et al.  Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides. , 2000, European journal of biochemistry.

[9]  M. Mihm,et al.  Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. , 2000, Cancer research.

[10]  H. Ploegh,et al.  Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages , 2000, The Journal of experimental medicine.

[11]  H. Ploegh,et al.  Secreted cathepsin L generates endostatin from collagen XVIII , 2000, The EMBO journal.

[12]  A. Rudensky,et al.  The role of lysosomal proteinases in MHC class Il‐mediated antigen processing and presentation , 1999, Immunological reviews.

[13]  J. Deussing,et al.  Proteases involved in MHC dass II antigen presentation , 1999, Immunological reviews.

[14]  L. Devi,et al.  Inflammatory Mediators Regulate Cathepsin S in Macrophages and Microglia: A Role in Attenuating Heparan Sulfate Interactions , 1999, Molecular medicine.

[15]  D. Turk,et al.  Crystal structure of MHC class II‐associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S , 1999, The EMBO journal.

[16]  G. Dranoff,et al.  Cathepsin S required for normal MHC class II peptide loading and germinal center development. , 1999, Immunity.

[17]  A. Rudensky,et al.  Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. , 1999, Immunity.

[18]  R. Gentz,et al.  Cystatin F Is a Glycosylated Human Low Molecular Weight Cysteine Proteinase Inhibitor* , 1998, The Journal of Biological Chemistry.

[19]  S. Menon,et al.  Leukocystatin, A New Class II Cystatin Expressed Selectively by Hematopoietic Cells* , 1998, The Journal of Biological Chemistry.

[20]  I. Mellman,et al.  Developmental Regulation of Invariant Chain Proteolysis Controls MHC Class II Trafficking in Mouse Dendritic Cells , 1998, Cell.

[21]  R. Mitchell,et al.  Cathepsin S activity regulates antigen presentation and immunity. , 1998, The Journal of clinical investigation.

[22]  A. Rudensky,et al.  Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. , 1998, Science.

[23]  M. Riedinger,et al.  Targeted Expression of Major Histocompatibility Complex (MHC) Class II Molecules Demonstrates that Dendritic Cells Can Induce Negative but Not Positive Selection of Thymocytes In Vivo , 1997, The Journal of experimental medicine.

[24]  R. Ménard,et al.  Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. , 1996, Biochemistry.

[25]  H. Ploegh,et al.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. , 1996, Immunity.

[26]  V. Turk,et al.  Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L , 1996, The Journal of experimental medicine.

[27]  H. Ruley,et al.  H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.

[28]  P. Cresswell.  Invariant Chain Structure and MHC Class II Function , 1996, Cell.

[29]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[30]  M. Taylor,et al.  Endosomal aspartic proteinases are required for invariant-chain processing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Fox,et al.  Potent slow-binding inhibition of cathepsin B by its propeptide. , 1992, Biochemistry.

[32]  M. Anderson,et al.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[34]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[35]  R. Crawford,et al.  Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4. , 1989, Journal of immunology.

[36]  H. Karasuyama,et al.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.

[37]  S. Gordon,et al.  Optimal conditions for proliferation of bone marrow‐derived mouse macrophages in culture: The roles of CSF‐1, serum, Ca2+, and adherence , 1983, Journal of cellular physiology.

[38]  S. Koch,et al.  Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody , 1982, Nature.

[39]  T. Springer,et al.  A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. , 1981, Journal of immunology.

[40]  J. Guarneri.  Influence of acute exposure to cigarette smoke on the alveolar macrophage system. , 1977, The Journal of laboratory and clinical medicine.

[41]  L. Moreland.  MHC class II molecules , 2004 .

[42]  L. Santambrogio,et al.  IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. , 2002, Journal of immunology.

[43]  V. Turk,et al.  Interaction of cystatin C variants with papain and human cathepsins B, H and L. , 1999, Journal of enzyme inhibition.

[44]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[45]  P. Cresswell,et al.  HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. , 1995, Cell.

[46]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[47]  H. Ploegh,et al.  Intracellular transport of MHC class II molecules. , 1992, Immunology today.

[48]  E. Shaw,et al.  The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor. , 1989, The Biochemical journal.